$50.42
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Crinetics Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Crinetics Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.94 | $-0.86 | -9.30 % |
Mar 2024 | 2024-05-09 | $-0.93 | $-0.81 | -14.8 % |
Dec 2023 | 2024-02-28 | $-0.90 | $-0.86 | -4.65 % |
Sep 2023 | 2023-11-07 | $-1.01 | $-0.91 | -11.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $399.00K | $460.00K | -13.3 % |
Mar 2024 | 2024-05-09 | $640.00K | $260.00K | 146.2 % |
Dec 2023 | 2024-02-28 | $0 | $260.00K | -100.0 % |
Sep 2023 | 2023-11-07 | $346.00K | $120.00K | 188.3 % |
Crinetics Pharmaceuticals (CRNX) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.94, which missed the estimate of $-0.86.
The Actual Revenue was $399K, which missed the estimate of $460K.
Browse earnings estimates, EPS, and revenue on all stocks.